skip to Main Content
Menu

Denise Deakin
President & Co-Founder

Denise possesses over 25 years of pharmaceutical industry experience and holds a nursing diploma and a BSc. from the University of Montreal. She began her career as a registered nurse, gaining pertinent clinical research experience as a clinical investigative team member and then as a Senior Clinical Research Associate, at Rhone-Poulenc Rorer (now Sanofi).

In 1997, Denise along with her business partner Andrée launched Scimega, Canada’s first oncology CRO. As President & co-Founder of Scimega, she has an unwavering passion to serve sponsors, oncologists and cancer patients in a way that makes a meaningful difference and leaves a lasting impression.

Denise oversees the corporate strategies developed by the Board of Directors and provides executive direction for Business Development/Marketing, Oncology Strategy/Alliances, and Quality Management.

Andrée Marceau
General Manager & Co-Founder

Andrée possesses 25 years of pharmaceutical industry experience and holds a BSc.N. from the University of Montreal and a B.B.A. from the University of Sherbrooke. She began her career as a registered nurse, and gained her oncology clinical research experience as a clinical investigative team member and then as a Clinical Research Associate and Drug Safety Manager, at Rhone-Poulenc Rorer (Aventis).

In 1997, Andrée along with her business partner Denise launched Scimega, Canada’s first oncology CRO. As General Manager & Co-Founder, Andrée has an unwavering commitment to business integrity and efficiency.

Andrée oversees the corporate strategies developed by the Board of Directors and provides executive management to the Directors of Clinical Operations, Human Resources and Finance.

Nathan Currier, PhD
Director, Oncology Strategy & Alliances

Nathan currently heads Scimega’s oncology strategy and alliances portfolio and is responsible for the planning and implementation of partnership development initiatives with oncology research organizations in Canada through his leadership of Scimega’s Reverse Feasibility™ Program. He joined Scimega in 2016 and brings over 20 years of scientific research and business experience to the company.

After a 2-year post-Doctoral appointment in industrial oncology research following his PhD, Nathan has since gained over 13 years of experience in oncology research in multiple malignant indications, business development, and partnership management in several industrial, non-profit, and academic organizations.

Nathan holds a PhD in molecular and cellular biology from McGill University in Montreal, Canada, where he studied the role of Natural Killer cells as a potential immunotherapy treatment for acute erythroid leukemia (counterpart to Di Guglielmo syndrome in humans). Nathan is a member of Scimega’s Board of Directors.

He is also an active member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the American Association of Cancer Research (AACR).

Julie Martin, MSc, MBA
Director, Clinical Operations

Julie has developed an expertise in managing a wide array of oncology clinical trials set in early and late clinical development stages including collaborative efforts with larger CROs. At Scimega she is responsible for the strategic planning, conduct and oversight of oncology clinical trials across Canada, and for the development of project proposals.  In addition, Julie serves as Director, Business Development, and is a member of Scimega’s managing Board of Directors.  She received her Master of Science in Biochemistry from the University of Montreal, during which she studied the regulation of  β-estrogen receptors in the context of breast cancer at the CHU Sainte-Justine Research Center, a leading Canadian mother-child research institution.  Julie also holds a Master of Business Administration from Concordia University.  She is a member of the American Society of Clinical Oncology (ASCO) and the Society of Clinical Research Associates (SoCRA).

Catherine Ménard, MSc
Director of Quality and Human Resources

Catherine currently serves as Scimega’s Director of Quality and Human Resources. She is dedicated to the successful conduct of oncology clinical trials in Canada and is responsible for building a talented, stable and highly motivated workforce at the company.

Catherine joined Scimega in 2006 as a Clinical Research Associate. She has over 16 years of experience in medical research, mainly in oncology clinical research and has worked in both the hospital and biopharmaceutical settings. She began her research activities in functional brain imaging and later in stem cell research with top researchers in Canada. She also played a key role in the management of a European multicenter oncology research project at the oncology hospital, Jules Bordet Institute in Brussels.

She holds a Masters degree in Neurosciences from University of Montreal and is a member of Scimega’s Board of Directors.

Geneviève Piché
Director of Finance

Geneviève currently serves as the Director of Finance and is responsible for all financial aspects of the company. In addition, she also oversees all the IT requirements for the company.

Geneviève joined Scimega in 2010 and brings over 10 years of experience in accounting, financial analysis and payroll administration. In her role as Director of Finance, she is responsible for leading the finance organization and supporting strategic planning and business operations. As a member of the Board of Directors, she also supports planning and execution of enhancements to support company growth.

HOW WE RATE

4-out of-5 Site evaluations rate Scimega services as superior compared to other CROs worked with.

Sign up to Canadian Oncology Clinical Trial News

Receive updates from our blog, podcasts and resource library.

Back To Top
Close search
Search